Avidan Neumann
机构: Helmholtz Center Munich, University Hospital Augsburg
每年引用次数
引用次数
引用: 28,724
H-指数: 59
I10-指数 : 141
出版物: 360
Viral kinetics of HCV genotype 5 in South Africa patients treated with pegylated-interferon-alpha and Ribaviron
M Nieuwoudt , Schalk Van der Merwe , A Arazi , A Neumann
Hepatology 46 ( 4)
2
2007
Vorhersage des virologischen Ansprechens bei HCV Genotyp 1a-infizierten Patienten anhand eines Aminosäure Musters im NS5A Protein
M von Wagner , C Welsch , E Herrmann , C Sarrazin
Zeitschrift Fur Gastroenterologie 45 ( 08) 357
2007
IL28B polymorphism is significantly correlated with ifn anti-viral effectiveness already on first day of pegylated interferon-alpha and ribavirin therapy of chronic HCV infection
A Neumann , S Bibert , B Haagmans , A Soulier
45th Annual Meeting of the European Association for the Study of Liver 52
20
2010
1606| Nasal biomarker-profiles to distinguish between high-and low-symptomatic, non-allergic and allergic subjects in a natural pollen exposure study
M Gökkaya , A Damialis , T Nussbaumer , I Beck
Albuferon (TM)-A novel therapeutic agent for hepatitis C: Results of a phase 1/2 study in treatment experienced subjects with chronic hepatitis C
V Balan , M Sulkowski , D Nelson , G Everson
Hepatology 40 ( 4) 280A -281A
11
2004
Modulation of interferon specific gene expression by albuferon (TM) in subjects with chronic hepatitis C and correlation with anti-viral response
P Moore , V Balan , D Nelson , M Sulkowski
JOURNAL OF HEPATOLOGY 42 162 -163
1
2005
Early viral kinetics in patients with chronic hepatitis C and end stage renal disease during therapy with peginterferon alfa-2a
GA Lutchman , A Neumann , M Ghany , T Heller
HEPATOLOGY 42 ( 4) 666A -667A
2005
Newly Established In-Depth T-Cell Receptor Repertoire Analysis by High-Throughput Sequencing Allows T-Cell Tracking and Differential Diagnosis of Virus-Associated Diseases Exemplified by BKV-Associated Nephropathy
M Dziubianau , A Sattler , J Hecht , H Trydzenskaya
AMERICAN JOURNAL OF TRANSPLANTATION 12 112 -112
2012
Lack of effect of ribavirin (RBV) on early HCV kinetics when combined with peginterferon alfa-2a (pIFN)
GA Lutchman , A Neumann , M Ghany , T Heller
Gastroenterology 126 ( 4) A668 -A668
1
2004
Experimental and computational analysis of contaminants in skin microbiome research
C Huelpuesch , T Nussbaumer , M Reiger , V Schwierzeck
EXPERIMENTAL DERMATOLOGY 27 40 -40
2018
Triple correlation between skin microbiome, skin barrier and immune gene expression pathways in atopic dermatitis
C Traidl-Hoffmann , T Nussbaumer , M Reiger , C Altunbulakli
EXPERIMENTAL DERMATOLOGY 27 32 -32
2018
Early HCV genotype 4 replication kinetics during treatment with peginterferon alfa-2a (Pegasys)-ribavirin combination. A comparison with HCV genotypes 1 and 3 kinetics.
JM Pawlotsky , C Hezode , B Pellegrin , A Soulier
Hepatology 36 ( 4) 291A -291A
27
2002
HBV viral dynamics in chronic hepatitis B patients treated with adefovir dipivoxil: Effect of dose and pretreatment HBV disease chracteristics.
A Neumann , M Shmailov , M Tsiang , B Kearney
Hepatology 36 ( 4) 375A -375A
3
2002
Comparable antiviral response rates with albinterferon alfa-2b dosed at Q2W or Q4W intervals in naïve subjects with genotypes 2 or 3 chronic hepatitis C
VG Bain , P Maretta , K Kaita , E Yoshida
42nd Annual Meeting of the European Association for the Study of the Liver (EASL). Oral presentation 12
2
2007
Association between liver histology, viral kinetics and outcome of therapy with peginterferon alpha-2a combination therapy with ribavirin in interferon naive patients with chronic hepatitis C
M Lagging , J Westin , P Dhillon , A Romero
JOURNAL OF HEPATOLOGY 42 209 -209
1
2005
Early distinct immune responses in COVID-19 vaccine-breakthrough versus non-vaccinated patients
C Holetschek , M Goekkaya , D Luschkova , P Eder
EXPERIMENTAL DERMATOLOGY 33 ( 3)
2024
Cytokine identification in seroma fluid after mastectomy in breast cancer patients–first results of SerMa pilot study subgroup
N Ditsch , N Pochert , M Schneider , M Köpke
European Journal of Cancer 175 S86 -S86
2022
Serom-Entstehung nach Mastektomie–ein möglicher (auto-) immunologischer Prozess?
N Ditsch , M Schneider , N Pochert , N Ansorge
Senologie-Zeitschrift für Mammadiagnostik und-therapie 19 ( 02) 0028 -0028
2022
48P T-helper cell-driven immune response as an effect for seroma formation (SF) after mastectomy (ME) in breast cancer (BC)(SerMa pilot EUBREAST 5)
N Ditsch , M Schneider , N Pochert , N Ansorge
Annals of Oncology 33 S143 -S143
2022
Supporting next-generation sequencing results via absolute quantification
C Huelpuesch , A de Tomassi , A Neumann , M Reiger
EXPERIMENTAL DERMATOLOGY 30 ( 3) E3 -E3
2021